• Explore /
  • Poster
  • / FRONTiER: A feasibility trial of nivolumab with neoadjuvant CF or DCF therapy for locally advanced esophageal carcinoma (JCOG1804E)—The short-term results of cohort A and B.

FRONTiER: A feasibility trial of nivolumab with neoadjuvant CF or DCF therapy for locally advanced esophageal carcinoma (JCOG1804E)—The short-term results of cohort A and B.

Abstract Poster

Authors

null

Shun Yamamoto

Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan

Shun Yamamoto , Ken Kato , Hiroyuki Daiko , Takashi Kojima , Hiroki Hara , Tetsuya Abe , Yasuhiro Tsubosa , Hirofumi Kawakubo , Takeo Fujita , Takashi Fukuda , Shigenori Kadowaki , Takahiro Tsushima , Yasuo Hamamoto , Kengo Nagashima , Kazunori Aoki , Yukihiro Mizoguchi , Shigehisa Kitano , Shinichi Yachida , Satoshi Shiba , Yuko Kitagawa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Esophageal and Gastric Cancer

Track

Esophageal and Gastric Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03914443

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr 202)

DOI

10.1200/JCO.2021.39.3_suppl.202

Abstract #

202

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Satoru Matsuda

First Author: Takako Yoshii

First Author: Manabu Muto

First Author: Satoru Matsuda